Product Information

LEVOXYL 175 MCG TABLET is a brand product labeled by Pfizer Inc., priced at $1.3893 per EA under NDC 60793085910. Its NADAC has been published 614 times since Nov 19, 2014.

FDA first approved this application on May 25, 2001. Its Orange Book therapeutic-equivalence code is AB1,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOXYL 175 MCG TABLET

levothyroxine sodium
$1.3893per EA

Strength

175 ug/1

Manufacturer

Pfizer Inc.

NDC

60793085910

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021301

FDA Approved

5/25/2001

TE Code

AB1,AB3

On Market Since

5/25/2001

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOXYL 175 MCG TABLET has been published 614 times since Nov 19, 2014, and over the history we have for it it has risen 114.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3893 per EA
All-time high$1.3903 (May 13, 2026)
All-time low$0.6482 (Nov 19, 2014)
52-week high$1.3903
52-week low$1.3212
Median price$1.2397
Average price$1.1660
Largest weekly change+9.4% (Jul 4, 2018)
Weeks tracked614
Tracking sinceNov 19, 2014

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

+4.9%

3Y

+7.0%

5Y

+12.4%

All

+114.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVOXYL 175 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOXYL 175 MCG TABLET, manufactured by Pfizer Inc., is $1.3893 per EA (NDC 60793085910), effective Aug 19, 2026.

How has the price of LEVOXYL 175 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOXYL 175 MCG TABLET has risen 114.3%. It has been tracked across 614 weekly CMS publications since Nov 19, 2014.

What are the highest and lowest recorded NADAC prices for LEVOXYL 175 MCG TABLET?

Since Nov 19, 2014, the NADAC for LEVOXYL 175 MCG TABLET has ranged from a low of $0.6482 (Nov 19, 2014) to a high of $1.3903 (May 13, 2026), with a median of $1.2397 per EA.

Are there cheaper alternatives to LEVOXYL 175 MCG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOTHYROXINE 175 MCG TABLET, is $0.0765 per EA — about 94% below LEVOXYL 175 MCG TABLET.

Who manufactures LEVOXYL 175 MCG TABLET?

LEVOXYL 175 MCG TABLET (NDC 60793085910) is labeled by Pfizer Inc., and CMS classifies it as a brand product.